how long does tirzepatide delay gastric emptying Avoid Gastroparesis on Tirzepatide: Safe Dosing Strategies Independent Nurse - Diabetic gastroparesis:

This dual action may explain its superior performance

According to the MHRA-approved Summary of Product Characteristics (SmPC), the most frequent side effects include nausea (reported in 43.9% of patients), diarrhoea (29.7%), vomiting (24.5%), constipation (24.2%), and abdominal pain (27.2%)

The two primary MTHFR variants are C677T (rs1801133) which substitutes valine for alanine at position 222, reducing enzyme activity by approximately 35% in heterozygotes and 70% in T/T homozygotes at physiological folate concentrations and A1298C (rs1801131) which substitutes glutamate for alanine at position 429, reducing activity by approximately 20% in heterozygotes, with compound heterozygosity (C677T + A1298C) producing effects between the two individual homozygous states

Clinical References 1 Wilding JPH, et al